NASDAQ: ALKSAlkermes PLC Stock Ownership - Who owns Alkermes?
Insider buying vs selling
Have Alkermes PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Joseph Gaffin | EVP CLO Alkermes Inc. | 2025-08-03 | 895 | $26.55 | $23.76kSell |
| Christian Todd Nichols | SVP Chief Commercial Officer | 2025-06-10 | 3,334 | $31.09 | $103.65kSell |
| Christian Todd Nichols | SVP Chief Commercial Officer | 2025-06-09 | 3,333 | $31.95 | $106.49kSell |
| Christopher I. Wright | Director | 2025-06-08 | 793 | $31.71 | $25.15kSell |
| Brian P. McKeon | Director | 2025-05-31 | 1,924 | $30.61 | $58.89kSell |
| Cato T. Laurencin | Director | 2025-05-31 | 1,924 | $30.61 | $58.89kSell |
| Christopher I. Wright | Director | 2025-05-31 | 1,924 | $30.61 | $58.89kSell |
| Nancy Lynn Md Snyderman | Director | 2025-05-31 | 1,924 | $30.61 | $58.89kSell |
| Nancy Lurker | Director | 2025-05-31 | 1,924 | $30.61 | $58.89kSell |
| Shane Cooke | Director | 2025-05-31 | 4,175 | $30.61 | $127.80kSell |
ALKS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALKS insiders and whales buy or sell their stock.
ALKS Shareholders
What type of owners hold Alkermes PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 16.87% | 27,856,163 | $751.28M | Institution |
| Vanguard Group Inc | 11.21% | 18,503,074 | $499.03M | Institution |
| Price T Rowe Associates Inc | 6.08% | 10,041,900 | $270.83M | Institution |
| State Street Corp | 4.97% | 8,208,256 | $221.38M | Institution |
| Elan Corp PLC | 4.69% | 7,750,000 | $209.02M | Insider |
| Baker Bros Advisors LP | 3.88% | 6,410,603 | $172.89M | Institution |
| Renaissance Technologies LLC | 3.52% | 5,810,160 | $156.70M | Institution |
| Jpmorgan Chase Co | 2.93% | 4,836,294 | $130.43M | Institution |
| Rtw Investments LP | 2.84% | 4,682,289 | $126.28M | Institution |
| Geode Capital Management LLC | 2.44% | 4,023,552 | $108.52M | Institution |
ALKS vs Pharmaceutical Stocks
Alkermes Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.